{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:16Z","timestamp":1786985416475,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["FQM-134"],"award-info":[{"award-number":["FQM-134"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["15135"],"award-info":[{"award-number":["15135"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/50006\/2020"],"award-info":[{"award-number":["UIDB\/50006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bmc.2022.116807","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T02:04:10Z","timestamp":1652061850000},"page":"116807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"68","author":[{"given":"Amina","family":"Moutayakine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Bagetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Leitzbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hagenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete P.","family":"Carreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Alcaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 G.","family":"Fern\u00e1ndez-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.116807_b0005","unstructured":"(a) WHO, Dementia, 2020. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia. Accessed 30 December 2021. (b) Patterson C. World Alzheimer Report 2018: The state of the art of dementia research: New frontiers; Sep 2018. (c) Gauthier S, Rosa-Neto P, Morais J.A, Webster C. World Alzheimer Report 2021: Journey through the diagnosis of dementia. London, England: Alzheimer\u2019s Disease International; 2021."},{"key":"10.1016\/j.bmc.2022.116807_b0010","doi-asserted-by":"crossref","first-page":"12259","DOI":"10.1021\/acsomega.9b01557","article-title":"Anti-Alzheimer\u2019s Disease Activity of Bromophenols from a Red Alga, Symphyocladia latiuscula (Harvey) Yamada","volume":"4","author":"Paudel","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2022.116807_b0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/acs.jmedchem.8b00760","article-title":"Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds","volume":"62","author":"Proschak","year":"2019","journal-title":"J Med Chem."},{"issue":"103753","key":"10.1016\/j.bmc.2022.116807_b0020","article-title":"N-1,2,3-triazole-isatin derivatives for cholinesterase and \u03b2-amyloid aggregation inhibition: A comprehensive bioassay study","volume":"98","author":"Marques","year":"2020","journal-title":"Bioorg Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0025","first-page":"3580","article-title":"Design, Synthesis and Bioassays of 3-Substituted-3-Hydroxyoxindoles for Cholinesterase Inhibition","volume":"1","author":"Totobenazara","year":"2016","journal-title":"Chem Select."},{"key":"10.1016\/j.bmc.2022.116807_b0030","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3390\/ijms20123056","article-title":"The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases","volume":"20","author":"Maher","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bmc.2022.116807_b0035","unstructured":"a) Pettersson M, Johnson D.S, Rankic D.A, et al. Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione \u03b3-secretase modulators with robust central efficacy.MedChemComm. 2017; 8:730\u2013743.10.1039\/c6md00406g b) Singh M, Kaur M, Singh N, Silakari O.Exploration of multi-target potential of chromen-4-one based compounds in Alzheimer's disease: Design, synthesis and biological evaluations. Bioorg Med Chem. 2017; 26:4360\u20134361. 10.1016\/j.bmc.2017.09.012 c) Wallace T.W, Saengchantara S.T. Chromanols, chromanones, and chromones Nat Prod Rep 1986; 3:465-475. 10.1039\/NP9860300465 d) Ellis G.P. Chromenes, Chromanones, and Chromones, Chemistry of Heterocyclic Compounds. vol 100. John Wiley & Sons; 2009. e) Emami S, Ghanbarimasir Z. Recent advances of chroman-4-one derivatives: synthetic approaches and bioactivities. Eur J Med Chem. 2015; 93:539-563. 10.1016\/j.ejmech.2015.02.048."},{"key":"10.1016\/j.bmc.2022.116807_b0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bmc.2015.01.042","article-title":"Design, synthesis and evaluation of chromone-2-carboxamido-alkylbenzylamines as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"23","author":"Liu","year":"2015","journal-title":"Bioorg Med Chem."},{"issue":"103027","key":"10.1016\/j.bmc.2022.116807_b0045","article-title":"Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with \u03b2-amyloid anti-aggregation properties for the treatment of Alzheimer\u2019s disease","volume":"89","author":"Jiang","year":"2019","journal-title":"Bioorg Chem."},{"issue":"7104\u20137113","key":"10.1016\/j.bmc.2022.116807_b0050","article-title":"Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors.J","volume":"55","author":"Frid\u00e9n-Saxin","year":"2012","journal-title":"Med Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0055","doi-asserted-by":"crossref","unstructured":"Chin K.-Y, Tay S.S. A Review on the Relationship between Tocotrienol and Alzheimer Disease.Nutrients. 2018; 10:881 10.3390\/nu10070881.","DOI":"10.3390\/nu10070881"},{"key":"10.1016\/j.bmc.2022.116807_b0060","doi-asserted-by":"crossref","first-page":"6717","DOI":"10.1021\/jm501690r","article-title":"New Frontiers in Selective Human MAO-B Inhibitors","volume":"58","author":"Carradori","year":"2015","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0065","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1039\/C5MD00124B","article-title":"Chromanones: selective and reversible monoamine oxidase B inhibitors with nanomolar potency","volume":"6","author":"Lan","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmc.2022.116807_b0070","doi-asserted-by":"crossref","unstructured":"a) Voight E.A, Daanen J.F, Hannick S.M, Shelat B.H, Kerdesky F.A, Plata D.J, Kort M.E. Efficient and general asymmetric syntheses of (R)-chroman-4-amine salts. Tetrahedron Lett. 2010; 51:5904\u20135907. 10.1016\/j.tetlet.2010.09.006 b) Lloyd J, Atwal K.S, Finlay H.J, Nyman M, Huynh T, Bhandaru R, Kover A, Schmidt J, Vaccaro W, Conder M.J, Jenkins-West T, Levesque P. Benzopyran sulfonamides as KV1.5 potassium channel blockers. Bioorg Med Chem Lett. 2007; 17:3271\u20133275.10.1016\/j.bmcl.2007.04.020.","DOI":"10.1016\/j.bmcl.2007.04.020"},{"key":"10.1016\/j.bmc.2022.116807_b0075","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bmcl.2009.10.134","article-title":"Synthesis and structure\u2013activity relationship of novel lactam-fused chroman derivatives having dual affinity at the 5-HT1A receptor and the serotonin transporter","volume":"20","author":"Shen","year":"2010","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmc.2022.116807_b0080","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jchemneu.2019.01.008","article-title":"Protective effects of 5-HT1A receptor antagonist and 5-HT2A receptor agonist on the biochemical and histological features in a rat model of Alzheimer's disease","volume":"96","author":"Afshar","year":"2019","journal-title":"J Chem Neuroanat."},{"key":"10.1016\/j.bmc.2022.116807_b0085","doi-asserted-by":"crossref","first-page":"8561","DOI":"10.1021\/acs.joc.6b01750","article-title":"Catalytic Asymmetric Decarboxylative Mannich Reaction of Malonic Acid Half Esters with Cyclic Aldimines: Access to Chiral \u03b2-Amino Esters and Chroman-4-amines","volume":"81","author":"Jia","year":"2016","journal-title":"J Org Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0090","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ajpath.2013.01.021","article-title":"The Bradykinin B1 Receptor Regulates A\u03b2 Deposition and Neuroinflammation in Tg-SwDI Mice","volume":"182","author":"Passos","year":"2013","journal-title":"Amer J Path."},{"key":"10.1016\/j.bmc.2022.116807_b0095","first-page":"11333","article-title":"Novel Palladium-Catalyzed Intramolecular Addition of Aryl Bromides to Aldehydes as Key to the Synthesis of 3,3-Dimethylchroman-4-ones and 3,3-Dimethylchroman-4-ols","volume":"3","author":"Viana","year":"2018","journal-title":"Chem Select."},{"key":"10.1016\/j.bmc.2022.116807_b0100","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1021\/acs.jmedchem.7b00315","article-title":"Natural-Products-Inspired Use of the gem-Dimethyl Group in Medicinal Chemistry","volume":"61","author":"Talele","year":"2018","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0105","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(97)00093-4","article-title":"Arisugacins, selective acetylcholinesterase inhibitors of microbial origin","volume":"76","author":"Otoguro","year":"1997","journal-title":"Pharmacol Ther."},{"issue":"5908","key":"10.1016\/j.bmc.2022.116807_b0110","article-title":"Parameters for Irreversible Inactivation of Monoamine Oxidase","volume":"25","author":"Ramsay","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2022.116807_b0115","unstructured":"Bacalhau, P., Mechanism of Action and Promising Treatments for Neurodegenerative Diseases, PhD thesis, University of Evora, 2018."},{"key":"10.1016\/j.bmc.2022.116807_b0120","doi-asserted-by":"crossref","unstructured":"Claridge T.D.W. High-Resolution NMR Techniques in Organic Chemistry, 3rd Edition. Oxford, Elsevier; 2016.","DOI":"10.1016\/B978-0-08-099986-9.00002-6"},{"key":"#cr-split#-10.1016\/j.bmc.2022.116807_b0125.1","doi-asserted-by":"crossref","unstructured":"(a) Totobenazara J, Bacalhau P, San Juan A, et al. Design, Synthesis and Bioassays of 3-Substituted-3-Hydroxyoxindoles for Cholinesterase Inhibition. Chem Select. 2016;1:3580-3588. 10.1002\/slct.201600932 (b) Bacalhau P, Fernandes L, Candeias F, et al. In silico, NMR and pharmacological evaluation of an hydroxyoxindole cholinesterase inhibitor. Bioorg Med Chem. 2019","DOI":"10.1002\/slct.201600932"},{"key":"#cr-split#-10.1016\/j.bmc.2022.116807_b0125.2","doi-asserted-by":"crossref","unstructured":"27:354-363. 10.1016\/j.bmc.2018.12.007 (c) Bacalhau P, San Juan A.A, Goth A, et al. Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR). Bioorg. Chem. 2016","DOI":"10.1016\/j.bioorg.2016.06.002"},{"key":"#cr-split#-10.1016\/j.bmc.2022.116807_b0125.3","doi-asserted-by":"crossref","unstructured":"(a) Totobenazara J, Bacalhau P, San Juan A, et al. Design, Synthesis and Bioassays of 3-Substituted-3-Hydroxyoxindoles for Cholinesterase Inhibition. Chem Select. 2016;1:3580-3588. 10.1002\/slct.201600932","DOI":"10.1002\/slct.201600932"},{"key":"#cr-split#-10.1016\/j.bmc.2022.116807_b0125.4","doi-asserted-by":"crossref","unstructured":"(b) Bacalhau P, Fernandes L, Candeias F, et al. In silico, NMR and pharmacological evaluation of an hydroxyoxindole cholinesterase inhibitor. Bioorg Med Chem. 2019; 27:354-363. 10.1016\/j.bmc.2018.12.007","DOI":"10.1016\/j.bmc.2018.12.007"},{"key":"#cr-split#-10.1016\/j.bmc.2022.116807_b0125.5","doi-asserted-by":"crossref","unstructured":"(c) Bacalhau P, San Juan A.A, Goth A, et al. Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR). Bioorg. Chem. 2016; 67:105-109. 10.1016\/j.bioorg.2016.06.002.","DOI":"10.1016\/j.bioorg.2016.06.002"},{"key":"10.1016\/j.bmc.2022.116807_b0130","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.bmc.2022.116807_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.bmc.2022.116807_b0140","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/ci300447c","article-title":"Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area","volume":"26","author":"Ali","year":"2012","journal-title":"J. Chem. Inf. Mod."},{"key":"10.1016\/j.bmc.2022.116807_b0145","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bmc.2017.07.023","article-title":"Mapping the substrate scope of monoamine oxidase (MAO-N) as a synthetic tool for the enantioselective synthesis of chiral amines","volume":"26","author":"Herter","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol."},{"key":"10.1016\/j.bmc.2022.116807_b0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj1370143","article-title":"A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors","volume":"137","author":"Cornish-Bowden","year":"1974","journal-title":"Biochem J."},{"key":"10.1016\/j.bmc.2022.116807_b0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejmech.2018.02.015","article-title":"Novel indanone derivatives as MAO-B\/H3R dual-targeting ligands for treatment of Parkinson\u2019s disease","volume":"148","author":"Affini","year":"2018","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0165","unstructured":"Glide, Schr\u00f6dinger, LLC, New York, NY; 2018."},{"key":"10.1016\/j.bmc.2022.116807_b0170","unstructured":"Maestro, Schr\u00f6dinger LLC, New York, NY, USA; 2018."},{"key":"10.1016\/j.bmc.2022.116807_b0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bmc.2022.116807_b0180","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important Ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in vivo Activity","volume":"61","author":"Kosak","year":"2018","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmc.2022.116807_b0190","doi-asserted-by":"crossref","unstructured":"Reis J, Manzanella N, Cagide F, et al. Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis. J Med Chem. 201; 61: 4203-4212. 10.1021\/acs.jmedchem.8b00357.","DOI":"10.1021\/acs.jmedchem.8b00357"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:18:01Z","timestamp":1760836681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622001997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":42,"alternative-id":["S0968089622001997"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116807","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of chromane derivatives: Promising privileged scaffolds for lead discovery within Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116807"}}